| Name | 1-Benzyl-4-methyl-3-(methylamino)piperidine; |
|---|---|
| Synonyms |
1-Benzyl-N,4-dimethylpiperidin-3-amine
1-Benzyl-N-methyl-4-methylpiperidin-3-amine 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE (1-benzyl-4-methyl-piperidin-3-yl)-methyl-amine Tofacitinib Impurity F |
| Molecular Formula | C14H22N2 |
|---|---|
| Molecular Weight | 218.33800 |
| Exact Mass | 218.17800 |
| PSA | 15.27000 |
| LogP | 2.44520 |
| HS Code | 2933399090 |
|---|
|
~73%
384338-23-2 |
| Literature: AUSPEX PHARMACEUTICALS, LLC; RAO, Tadimeti, S.; ZHANG, Chengzhi Patent: WO2010/123919 A2, 2010 ; Location in patent: Page/Page column 51 ;WO 2010/123919 A2 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |